Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder
Jeffrey R. Strawn, Jeffrey A. Mills, Vikram Suresh, et al.
Journal of Psychiatric Research (2023) Vol. 159, pp. 266-273
Open Access | Times Cited: 18

Showing 18 citing articles:

At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data
David S. Mathai, Thomas D. Hull, Leonardo Vando, et al.
Journal of Affective Disorders (2024) Vol. 361, pp. 198-208
Open Access | Times Cited: 6
Clinical pharmacological innovation in the treatment of depression
Jeffrey M. Witkin, Lalit K. Golani, Jodi L. Smith
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 4, pp. 349-362
Closed Access | Times Cited: 13
Sociodemographic, clinical, and genetic factors associated with self-reported antidepressant response outcomes in the UK Biobank
Michelle Kamp, Chris Wai Hang Lo, Grigorios Kokkinidis, et al.
Psychological Medicine (2025) Vol. 55
Open Access
Treatment-resistant late-life depression prevalence and clinical/sociodemographic correlates: An electronic health records study
Beatriz Pozuelo Moyano, Vasiliki Orgeta, Armin von Gunten, et al.
Journal of Affective Disorders (2025)
Closed Access
Personalized venlafaxine dose prediction using artificial intelligence technology: a retrospective analysis based on real-world data
Yimeng Liu, Ze Yu, Xuxiao Ye, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 4, pp. 926-936
Closed Access | Times Cited: 4
Exploring perceived barriers and attitudes in young adults towards antidepressant pharmacotherapy, including the implementation of pharmacogenetic testing to optimize prescription practices
Bradley Roberts, Zahra Cooper, Georgia Landery, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Cognitive Deficits in Late-Life Depression: From Symptoms and Assessment to Therapeutics
Antônio Lúcio Teixeira, Allison Gregg, Melanie T. Gentry, et al.
FOCUS The Journal of Lifelong Learning in Psychiatry (2025) Vol. 23, Iss. 2, pp. 183-194
Closed Access
The gut microbiome from middle-aged women with depression modulates depressive-like behaviors and plasma fatty acid metabolism in female middle-aged mice
Huan Yu, Wenmao Yang, Yi-Huan Chen, et al.
Journal of Psychiatric Research (2024) Vol. 173, pp. 139-150
Closed Access | Times Cited: 3
Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study
Marco Di Nicola, Michael Adair, Andreas Rieckmann, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 7, pp. 615-623
Open Access | Times Cited: 2
Multi‐trial, aggregated, individual participant data mega‐analysis of short‐term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episode
Jay D. Amsterdam, Colin Xu
Bipolar Disorders (2023) Vol. 26, Iss. 3, pp. 255-264
Closed Access | Times Cited: 5
The Impact of Development on Antidepressant and Placebo Response in Anxiety Disorders: A Bayesian Hierarchical Meta-Analytic Examination of Randomized Controlled Trials in Children, Adolescents, and Adults
Jeffrey A. Mills, Eric Mendez, Jeffrey R. Strawn
Journal of Child and Adolescent Psychopharmacology (2024) Vol. 34, Iss. 7, pp. 302-309
Closed Access | Times Cited: 1
Safety and effectiveness of vortioxetine in patients with major depressive disorder in a real-life clinical setting in India: results from an interventional, flexible-dose study
Michael Adair, Rohini Bose, Simon Nitschky Schmidt
Current Medical Research and Opinion (2024) Vol. 40, Iss. 9, pp. 1637-1645
Open Access | Times Cited: 1
Genetics, epigenetics, and neurobiology of childhood-onset depression: an umbrella review
Manpreet K. Singh, Aaron J. Gorelik, Christopher D Stave, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 3, pp. 553-565
Closed Access | Times Cited: 3
TED (Trazodone Effectiveness in Depression): effectiveness of trazodone extended-release in subjects with unsatisfactory response to SSRIs
Marcin Siwek, Adrian Andrzej Chrobak, Anna Julia Krupa, et al.
Psychiatria Polska (2023), pp. 1-18
Open Access | Times Cited: 2
Exploring the Digital Landscape of Antidepressant Use: Demographic Insights, Emotional Analysis, and Topic Modeling (Preprint)
Jianfeng Zhu, Xinyu Zhang, Ruoming Jin, et al.
(2024)
Open Access
Exploring Youth-Perceived Barriers and Attitudes Towards the Clinical Use of Pharmacogenetic Testing to Optimise Antidepressant Pharmacotherapy
Bradley Roberts, Zahra Cooper, Georgia Landery, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Sociodemographic, clinical, and genetic factors associated with self-reported antidepressant response outcomes in the UK Biobank
Michelle Kamp, Chris Wai Hang Lo, Grigorios Kokkinidis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Association Between Pre-Hip Fracture Antidepressant Use and Post-Hip Fracture Length of Hospital Stay in Medicare Beneficiaries and Assessing Sex Differences
Rhea Mehta, Jason R. Falvey, Chixiang Chen, et al.
American Journal of Geriatric Psychiatry (2024)
Closed Access
Safety and efficacy of early augmentation with Transcranial Direct Current Stimulation (tDCS) in adolescents with Major Depressive Disorder: A Randomized controlled trial
Swapna Upadhyay, Vivek Agarwal, Amit Arya, et al.
Asian Journal of Psychiatry (2024) Vol. 103, pp. 104349-104349
Closed Access
Page 1

Scroll to top